AbstractÐThe ototoxic damage that drugs such as neomycin, kanamycin, colistin, cisplatin, transplatin and carboplatin cause on outer and inner hair cells in postnatal day 3 rat cochlear explants was investigated. Phalloidin±¯uorescein conjugate-stained stereocilia bundles of sensory hair cells were quanti®ed by video image analysis as a measurement of ototoxic eect. The video image quanti®cation system established dose±response curves for ototoxic drugs (e.g. calculation of an IC 50 ) and allowed comparisons between several ototoxins from the same family. This methodology provided the means to assess the ecacy of otoprotectant agents in preventing ototoxicity. Poly-l-aspartate (10 À5 M) and poly-l-glutamate (10 À5 M) protected auditory hair cells from neomycin (10 À3 M) toxicity while reduced glutathione (10 À3 M) provided protection against cisplatin (10 À4 M)-induced hair cell damage. # 1998 Published by Elsevier Science Ltd. All rights reserved Keywords: cochlea; aminoglycosides; cisplatin; ototoxicity; otoprotection.
INTRODUCTION
Hearing loss and impairment of balance are classical side-eects of important classes of therapeutic agents, for example, antibiotics of the aminoglycoside family and anticancer agents such as platin derivatives (Chiodo and Alberti, 1994; Harpur, 1981) . The primary targets of these drugs in the inner ear are the sensory hair cells of hearing and balance, but the molecular mechanisms that lead to hair cell death remain poorly understood.
Assessment of toxicity is a major concern in the pharmaceutical ®eld, and the development of in vitro systems that can rapidly screen for toxicity could help to avoid long, expensive in vivo studies. Therefore, the ®rst goal of the present study is to establish an in vitro semi-automatic system for the quanti®cation of ototoxic damage that would allow rapid screening of the auditory hair cells toxicity of new drugs or of new derivatives of known ototoxic drugs, in order to select new compounds and derivatives that have the best therapeutic eect/toxicity ratios. As ototoxic compounds may have dierent biochemical mechanisms of toxicity, we surmized that the number of hair cells would be a good common parameter for the evaluation of toxicity. Pattern recognition of the inner and outer hair cell stereocilia allows for the counting of these two types of auditory hair cells. Hair cell stereocilia and cuticular plates are known to be rich in F-actin ®laments that can be labelled with phalloidin± FITC, thereby allowing visualization of the normal pattern of stereocilia bundles of both the inner and outer hair cells, since there is no speci®c marker for hair cells.
One approach to minimize the functional consequences of ototoxic side-eects is to prevent ototoxic damage by co-administration of substances that decrease or suppress the drug's ototoxicity without interfering with their therapeutic eect.
In order to validate our in vitro model, we have quanti®ed the eects of several well-known ototoxic drugs: (1) antibacterial aminoglycosides (neomycin, kanamycin); (2) polypeptide antibiotics (colistin); and (3) antineoplastic drugs (cisplatin, carboplatin, transplatin) (Gandara et al., 1991; Koegel, 1985; WersaÈ ll, 1995) . In a second part, we have investigated the applicability of our system as a tool to screen for otoprotective agents. We have chosen the most ototoxic aminoglycoside and antineoplastic drugs, respectively neomycin and cisplatin, in order to evaluate the ecacy of potential protective agents in the in vitro model.
Besides hair cells toxicity, aminoglycosides antibiotics are known to be highly nephrotoxic agents by inducing death of kidney proximal tubule epithelial cells (Morin et al., 1980; Tulkens, 1989) . Several studies in rats have shown that poly-l-aspartic acid, a polyanionic agent, prevents or suppresses the nephrotoxic eects of aminoglycosides without decreasing their antibiotic eectiveness (Williams and Hottendorf, 1985; Williams et al., 1986) . We have therefore chosen to determine whether the reported prevention of nephrotoxicity could be eective in protecting the hair cells of the inner ear from ototoxic damage.
Reduced glutathione (GSH) has been shown to prevent the toxic peripheral neuropathy induced by cisplatin, both in experimental animals Hamers et al., 1993; Tredici et al., 1994) and in humans (Cascinu et al., 1995) . Therefore we also have assayed for an eect of GSH on cisplatin ototoxicity in vitro.
MATERIALS AND METHODS
Culture of explants containing the organ of Corti and the spiral ganglion 3-Day-old Wistar rats were killed by cervical transection, their bullae exposed and the temporal bones removed and transferred into a glass petri dish containing Dulbecco's phosphate buered saline (PBS). Using watchmaker forceps, cochleae were dissected with the aid of a stereomicroscope. After opening the bony capsule, the cochlear duct was removed as a single piece together with its band of spiral neurons. Explants were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with glucose (®nal concentration 6 g/ litre), the N 1 cocktail (Bottenstein and Sato, 1979) and 10% of foetal bovine serum (DMEM-FBS) into wells of a 96-well microculture plate (Nunc). Each explant of Corti's organ was cultured in suspension in individual wells containing 100 ml medium. The cultures were kept at 378C in a humidi®ed atmosphere of 95% air and 5% CO 2 . For toxicity screening, the medium was removed after an initial period of 24 hr of culture and, after two rinses with DMEM to remove the serum, replaced with 100 ml DMEM containing an appropriate concentration of the test drug for 48 hr, while control explants received only DMEM. For the screening of otoprotective substances, the explants were ®rst cultured in the presence of the potential otoprotective agent for an initial 24-hr period. The medium was then removed, and replaced by medium containing both the ototoxic drug and the potential otoprotectant for an additional 48 hr of culture. At the end of each experiment, the explant specimens were ®xed and stained for F-actin.
Tested substances
The toxicity of well known cochleotoxic drugs such as neomycin, kanamycin, colistin, cisplatin, carboplatin and transplatin were tested at concentrations ranging from 10 À3 to 10 À6 M (®ve concentrations at least per tested drug). Chloramphenicol, a non-ototoxic antibiotic was used as a control. The potential otoprotective agents tested were poly-laspartate (mol. wt 5000±15,000), poly-l-glutamate (mol. wt 2000±15,000) and poly-l-ornithine (mol. wt 5000±15,000) for neomycin and GSH for cisplatin.
Histochemical determination of F-actin
Explants were ®xed with paraformaldehyde 4% at room temperature for 30 min and then incubated in PBS-Triton X100 1% for 15 min. The ®xed-permeabilized cultures were subsequently exposed to phalloidin±FITC (1:60) for 45 min at room temperature. After 45 min, the explants were washed twice in PBS and mounted on glass slides with nonfading PBS/glycerol. In order to avoid variations due to base to apex gradients of susceptibility to ototoxic compounds (Harpur, 1987) , only midportions of the phalloidin FITC-stained explants corresponding to the midturn were selected. Immunostained stereocilia bundles were observed using a Bio-Rad MRC-1000 confocal system coupled to a Zeiss Axiovert microscope.
Quanti®cation of ototoxicity
The number of hair cells was determined by video imaging using an IBAS-2000 image analysis system (Kontron). Confocal ®les were transfered to the image analysis software. The ®rst step increased the image contrast by ®rst superimposing it 200-fold and, secondly,``normalized'' it by scaling the actual grey levels linearly into the full dynamic range of the image memory. In a second step, a threshold level of grey shading was established in order to detect all of the hair cell stereocilia bundles. A threshold low enough to detect all stereocilia bundles must be used, otherwise part of them will be lost during data acquisition and subsequent analysis. After this step, each object that was under threshold was in black and every object that was above threshold was in white thus allowing visual-ization of a digitized microscopic image. The background of cell debris or particulate matter was eliminated from the image by grey-level erosion. Every object was assigned its own object label for necessary identi®cation before counting. Computerrecognized immunostained stereocilia bundles were projected in colour over the original digitized microscopic image in order to compare the processed data with the original image. The length of the preparation was measured and the results were expressed in number of hair cell stereocilia bundles per millimetre of Corti's organ. For each condition, four adjacent ®elds selected from the midportion of each explant were analysed blindly for three explants representing each condition (total number of ®elds = 12). This program also allows dierential counting of outer (OHC) and inner hair cells (IHC) by manual separation in the stored digitized image of the three rows of outer hair cells from the row of inner hair cells. Statistical analysis was undertaken using a standard Student's t-test.
Products and reagents
DMEM and FCS were obtained from Gibco (Gent, Belgium). In all experiments, DMEM was supplemented with the N 1 cocktail (bovine insulin 5 mg/ml, progesterone 10 À8 M, putrescine 100 mM, transferrin 100 mg/ml and selenium 3 Â 10 À8 M) and the glucose concentration was increased to 6 g/litre. All reagents used were of analytical grade and were purchased from Sigma.
RESULTS

Image analysis of organ of Corti explants after phalloidin±FITC staining
It is well established that the mammalian organ of Corti is equipped with three rows of OHCs and a single row of IHCs and provided that each row has the same number of cells, quantitative data obtained from stereocilia bundles counts of normal organ of Corti explants should be composed of 75% OHCs and 25% IHCs. This is shown in 
Plate 1D) and carboplatin (10 À4 M, Plate 1E). Chloramphenicol (10 À3 M), a non-ototoxic antibiotic, was used as negative control (Plate 1F). As can be see in photomicrographs A,B,C, D and E of Plate 1, it is dicult to identify OHC and IHC in the treated cultures because of the disorganizing eect that these agents have on stereocilia bundle integrity. We have therefore established dose±response curves by considering only the total number of auditory hair cells per unit length. These curves have allowed the calculation of an IC 50 which corresponds to the concentration of the test drug at which 50% of the hair cells are no longer detectable by phalloidin±FITC staining (Table 2 ). In the analysis of ototoxic eects, it has been observed that equimolar concentrations of kanamycin are less toxic than neomycin, which ®ts with clinical data that show a greater ototoxicity for neomycin in clinical subjects (Harpur, 1989) . Similarly, equimolar concentrations of carboplatin have been found to be less toxic to auditory hair cells when compared with cisplatin. These observations also agree with clinical observations (Saito et al., 1989; Schweitzer et al., 1986; Taudy et al., 1992) .
Protective eect of poly-l-glutamic and poly-l-aspartic acid against neomycin toxicity Poly-l-ornithine (a polycationic agent) was used as a control for the investigation of the protective Each ®eld represents the quanti®cation of auditory hair cells in the middle part of an individual explant, n = 4.
eect of poly-l-aspartate and poly-l-glutamate (polyanionic agents). The protective eect on hair cell survival measured by quanti®cation of hair cells bundles of both poly-l-aspartate and poly-l-glutamate is presented in Plate 2 and Table 3 . A control explant is illustrated in Plate 2A and poly-l-aspartate and poly-l-glutamate exposed cultures had a similar appearance. The protective agents have no eect on hair cells morphology. No protection against the ototoxic eect of neomycin was obtained using poly-l-ornithine. Both polyanionic drugs, poly-l-aspartate and poly-l-glutamate, protect against neomycin-induced hair cell toxicity at the highest tested concentration, namely 10
Protective eect of GSH against cisplatin toxicity
The number of cisplatin-damaged hair cells is signi®cantly reduced in the presence of GSH (Plate 3), thus demonstrating a protective eect of GSH on cisplatin-induced hair cell damage. GSH alone has no eect on hair cell morphology or number (Plate 3A). Quantitative analysis of the protective eect of GSH is presented in Table 4 , and shows that 10 À3 M GSH had a signi®cant protective eect up to a 10 À4 M concentration of cisplatin but fails to protect at the 10 À3 M level of drug concentration. No protection was obtained using GSH (10 À3 M) and neomycin (10 À3 ±10 À4 M), showing that the mechanism of GSH otoprotection appears to be selective.
DISCUSSION
Auditory hair cells have been well established as the primary targets of various ototoxic agents, particularly with aminoglycosides antibiotics and anticancer platin derivatives (Kroese and Van den Bercken, 1980; Taudy et al., 1992) . Their death in the organ of Corti results in sensory deafness which, in humans, is irreversible. Loss of hearing threshold due to ototoxic poisoning of auditory hair cells in birds has been shown to be transient. Indeed, in avians, the damaged inner ear has been shown to self-repair through the process of hair cell regeneration (Ryals and Rubel, 1988) . As the induction of hair cell regeneration appears to be far away from clinical application in humans and since some ototoxic drugs still have to be administrated to the patient for life-threatening diseases, an otoprotection strategy should be developed in order to prevent damage to the inner ear. Such an approach has already been proposed, and the use of various molecules, such as radioprotectant (Pierson and Moller, 1981) , thyroid hormone (Hangfu et al., 1992) or high calcium concentrations (Takada and Schacht, 1982) , has been shown to be eective in protecting the inner ear from speci®c insults that result in hair cell degeneration. However, to achieve the goal of protecting hair cells from injury, we need to develop a reliable and fast model to screen potential ototoxic and otoprotective drugs. For this purpose, in vitro models appear to be suitable (Kotecha and Richardson, 1994; Richardson and Russell, 1991) and are currently used in our laboratory (Lefebvre et al., 1989 (Lefebvre et al., , 1990 (Lefebvre et al., , 1993 . The semi-automatic method of quanti®cation using a video image analysis system presented in this paper allows rapid and objective quanti®cation of the number of hair cells/mm of Corti's organ in organotypic explants. Using this technique, we have established dose±response curves and calculated IC 50 s, which allow comparisons between dierent drugs (see Table 2 ). This screening for ototoxic eects can potentially be extended to any existing or newly synthesized molecules with dierent mechanisms of ototoxicity. However, it is important to emphasize the limitations of our model, which are: (1) our method does not in the strict sense quantify hair cell death, but rather hair cell injury as demonstrated after phalloidin±FITC staining; (2) this in vitro model cannot explain or study the toxicologic molecular mechanism of the drugs; and (3) this in vitro system cannot reproduce the in vivo accumulation of ototoxic drugs, especially aminoglycosides, in the perilymph or the endolymph 
N.D. = non determined *Protection explants are pretreated with protective compound for 24 hr before exposure to neomycin. **Results are expressed in percentage of hair cells as compared to control cultures (mean 2 SD, n = 12). 6Statistically signi®cant compared with cultures exposed to neomycin alone. (Tran Ba Huy et al., 1981) . This could explain why high concentrations had to be used in order to observe an ototoxic eect.
Perhaps the most interesting application of this quanti®cation system is its ability to screen for substances that can be used to prevent the ototoxic side-eect of various drugs for which no alternative exists in terms of therapeutic strategies. In this study, we have selected as potential otoprotective agents, substances which could be used in the clinic and which have been found to protect other target organs from toxicity, namely polyanions and GSH.
Indeed, systemic administration of polyaminoacids, including poly-l-aspartic and poly-l-glutamic acid, has been reported to provide protection against the development of aminoglycoside-induced nephrotoxicity in the rat, as assessed by histopathology scoring, and to prevent functional and biochemical lesions (Ramsammy et al., 1988) . One of the objectives of this study was to extend and test in the inner ear the observation that poly-l-aspartate protects the rat kidney against the development of aminoglycosides nephrotoxicity. As can be seen in Plate 2 and Table 3 , poly-l-aspartate and poly-l-glutamate to a large extent protect auditory hair cells against neomycin-induced ototoxic damage in our in vitro model. Polyanions, such as poly-l-aspartate or polyl-glutamate, may protect against aminoglycoside ototoxicity by forming electrostatic complexes with these drugs and inhibiting their interaction with critical intracellular or extracellular target, as has been shown for the protection of their nephrotoxicity (Ramsammy et al., 1990) . Another hypothesis could be the direct interaction of the polyanion with the plasma membrane instead of the aminoglycosides, which may constitute one of the ®rst steps of their toxic mechanism of action (Schacht, 1986; Williams et al., 1987) . That type of protection is also speci®c for aminoglycoside antibiotics and explains why we have not found any protection against cisplatin ototoxicity (data not shown).
GSH is reported to diminish cisplatin-induced neurotoxicity, and patients treated with cisplatin in combination with GSH (doses ranging from 1.5 to 3 g/m 2 ) exhibit a less severe neuropathic syndrome with no negative interference of its anticancer activity in these patients (Cavaletti et al., 1996; Colombo et al., 1995; Di Re et al., 1993) . Experimental studies performed on rats have shown that GSH provides protection against the cisplatininduced slowing of sensory nerve conduction velocity without interfering with the antitumour ecacy of this drug (Hamers et al., 1993) . Our in vitro data demonstrate that GSH also protects hair cells from cisplatin-induced injury, although not for the highest cisplatin concentration. However, histopathological studies of deafness resulting from cisplatin poisoning demonstrate that not only are hair cells damaged, but that auditory neurons are also injured (Schweitzer et al., 1986) . Therefore, similar investigations have to be undertaken to look for a potential protective eect of GSH on auditory neurons. This assumption seems reasonable since our preliminary data suggest that a protective eect of GSH occurs in vitro on adult rat dorsal root ganglion neurons, and since in vivo treatment with GSH decreases the platinum concentration in DRG neurons (Cavaletti et al., 1992) . The otoprotective mechanism has to be elucidated, since the mechanism of cisplatin ototoxicity is still unknown. Cisplatin ototoxicity may be a result of accumulation of reactive oxygen species (Rybak et al., 1995) ; in that case, GSH could protect by a detoxi®cation mechanism. A possible explanation is based on the chemical structure of cisplatin: GSH would form complexes with cisplatin thereby preventing the formation of similar complexes between cisplatin and macromolecules of the inner ear responsible of cisplatin ototoxicity, and such a protective mechanism would explain the absence of a GSH protective eect for aminoglycoside ototoxicity.
In conclusion, our results show that the potential protective molecules testedÐpolyanions and GSHÐ protect respectively against aminoglycosides and cisplatin derivatives ototoxicity. To what extent these data obtained in vitro on post-natal organ of Corti material will be con®rmed in vivo and lead to preservation of hearing remains to be shown. The in vitro screening model presented in this report allows, for the quanti®cation of ototoxicity, a comparison of relative toxicity of various drugs from the same family and the testing of otoprotective agents. This system provides a powerful tool for the design and evaluation of otoprotective strategies. Indeed, systemic administration of poly-l-aspartate was recently demonstrated to prevent the shift in the auditory brain stem response threshold that occurs with gentamicin treatment (Hulka et al., 1993) .
